New concepts for expressing forced expiratory volume in 1 s arising from survival analysis
Spirometric lung function is partly determined by sex, age and height (Ht). Commonly, lung function is expressed as a percentage of the predicted value (PP) in order to account for these effects. Since the PP method retains sex, age and Ht bias, forced expiratory volume in 1 s (FEV 1 ) standardised...
Saved in:
Published in | The European respiratory journal Vol. 35; no. 4; pp. 873 - 882 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Leeds
Eur Respiratory Soc
01.04.2010
Maney |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Spirometric lung function is partly determined by sex, age and height (Ht). Commonly, lung function is expressed as a percentage of the predicted value (PP) in order to account for these effects.
Since the PP method retains sex, age and Ht bias, forced expiratory volume in 1 s (FEV 1 ) standardised by powers of Ht and by a new sex-specific lower limit (FEV 1 quotient (FEV 1 Q)) were investigated to determine which method best predicted all-cause mortality in >26,967 patients and normal subjects.
On multivariate analysis, FEV 1 Q was the best predictor, with a hazard ratio for the worst decile of 6.9 compared to 4.1 for FEV 1 PP. On univariate analysis, the hazard ratios were 18.8 compared to 6.1, respectively; FEV 1 ·Ht −3 was the next-best predictor of survival. Median survival was calculated for simple cut-off values of FEV 1 Q and FEV 1 ·Ht −3 . These survival curves were accurately fitted (r 2 = 1.0) by both FEV 1 Q and FEV 1 ·Ht −3 values expressed polynomially, and so an individual's test result could be used to estimate survival (with sd for median survival of 0.22 and 0.61 yrs, respectively).
It is concluded that lung function impairment should be expressed in a new way, here termed the FEV 1 Q, or, alternatively, as FEV 1 ·Ht −3 , since these indices best relate spirometric lung function to all-cause mortality and survival. |
---|---|
AbstractList | Spirometric lung function is partly determined by sex, age and height (Ht). Commonly, lung function is expressed as a percentage of the predicted value (PP) in order to account for these effects. Since the PP method retains sex, age and Ht bias, forced expiratory volume in 1 s (FEV(1)) standardised by powers of Ht and by a new sex-specific lower limit (FEV(1) quotient (FEV(1)Q)) were investigated to determine which method best predicted all-cause mortality in >26,967 patients and normal subjects. On multivariate analysis, FEV(1)Q was the best predictor, with a hazard ratio for the worst decile of 6.9 compared to 4.1 for FEV(1)PP. On univariate analysis, the hazard ratios were 18.8 compared to 6.1, respectively; FEV(1) x Ht(-3) was the next-best predictor of survival. Median survival was calculated for simple cut-off values of FEV(1)Q and FEV(1) x Ht(-3). These survival curves were accurately fitted (r(2) = 1.0) by both FEV(1)Q and FEV(1) x Ht(-3) values expressed polynomially, and so an individual's test result could be used to estimate survival (with sd for median survival of 0.22 and 0.61 yrs, respectively). It is concluded that lung function impairment should be expressed in a new way, here termed the FEV(1)Q, or, alternatively, as FEV(1) x Ht(-3), since these indices best relate spirometric lung function to all-cause mortality and survival.Spirometric lung function is partly determined by sex, age and height (Ht). Commonly, lung function is expressed as a percentage of the predicted value (PP) in order to account for these effects. Since the PP method retains sex, age and Ht bias, forced expiratory volume in 1 s (FEV(1)) standardised by powers of Ht and by a new sex-specific lower limit (FEV(1) quotient (FEV(1)Q)) were investigated to determine which method best predicted all-cause mortality in >26,967 patients and normal subjects. On multivariate analysis, FEV(1)Q was the best predictor, with a hazard ratio for the worst decile of 6.9 compared to 4.1 for FEV(1)PP. On univariate analysis, the hazard ratios were 18.8 compared to 6.1, respectively; FEV(1) x Ht(-3) was the next-best predictor of survival. Median survival was calculated for simple cut-off values of FEV(1)Q and FEV(1) x Ht(-3). These survival curves were accurately fitted (r(2) = 1.0) by both FEV(1)Q and FEV(1) x Ht(-3) values expressed polynomially, and so an individual's test result could be used to estimate survival (with sd for median survival of 0.22 and 0.61 yrs, respectively). It is concluded that lung function impairment should be expressed in a new way, here termed the FEV(1)Q, or, alternatively, as FEV(1) x Ht(-3), since these indices best relate spirometric lung function to all-cause mortality and survival. Spirometric lung function is partly determined by sex, age and height (Ht). Commonly, lung function is expressed as a percentage of the predicted value (PP) in order to account for these effects. Since the PP method retains sex, age and Ht bias, forced expiratory volume in 1 s (FEV 1 ) standardised by powers of Ht and by a new sex-specific lower limit (FEV 1 quotient (FEV 1 Q)) were investigated to determine which method best predicted all-cause mortality in >26,967 patients and normal subjects. On multivariate analysis, FEV 1 Q was the best predictor, with a hazard ratio for the worst decile of 6.9 compared to 4.1 for FEV 1 PP. On univariate analysis, the hazard ratios were 18.8 compared to 6.1, respectively; FEV 1 ·Ht −3 was the next-best predictor of survival. Median survival was calculated for simple cut-off values of FEV 1 Q and FEV 1 ·Ht −3 . These survival curves were accurately fitted (r 2 = 1.0) by both FEV 1 Q and FEV 1 ·Ht −3 values expressed polynomially, and so an individual's test result could be used to estimate survival (with sd for median survival of 0.22 and 0.61 yrs, respectively). It is concluded that lung function impairment should be expressed in a new way, here termed the FEV 1 Q, or, alternatively, as FEV 1 ·Ht −3 , since these indices best relate spirometric lung function to all-cause mortality and survival. Spirometric lung function is partly determined by sex, age and height (Ht). Commonly, lung function is expressed as a percentage of the predicted value (PP) in order to account for these effects. Since the PP method retains sex, age and Ht bias, forced expiratory volume in 1 s (FEV(1)) standardised by powers of Ht and by a new sex-specific lower limit (FEV(1) quotient (FEV(1)Q)) were investigated to determine which method best predicted all-cause mortality in >26,967 patients and normal subjects. On multivariate analysis, FEV(1)Q was the best predictor, with a hazard ratio for the worst decile of 6.9 compared to 4.1 for FEV(1)PP. On univariate analysis, the hazard ratios were 18.8 compared to 6.1, respectively; FEV(1) x Ht(-3) was the next-best predictor of survival. Median survival was calculated for simple cut-off values of FEV(1)Q and FEV(1) x Ht(-3). These survival curves were accurately fitted (r(2) = 1.0) by both FEV(1)Q and FEV(1) x Ht(-3) values expressed polynomially, and so an individual's test result could be used to estimate survival (with sd for median survival of 0.22 and 0.61 yrs, respectively). It is concluded that lung function impairment should be expressed in a new way, here termed the FEV(1)Q, or, alternatively, as FEV(1) x Ht(-3), since these indices best relate spirometric lung function to all-cause mortality and survival. |
Author | Pedersen, O. F Miller, M. R |
Author_xml | – sequence: 1 fullname: Miller, M. R – sequence: 2 fullname: Pedersen, O. F |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22555362$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19741033$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU9v1DAQxS1URLeFD8AF-YI4pdgZ598RVVCQKrjAhYtlO5PWlWMvnmTLfvsm2t0eOHCwRvb83mie3wU7iykiY2-luJKyhY-iEyA7qK-EEGXViu4F20jougKEgDO2WfvFCpyzC6IHIWStQL5i57JrlBQAG_b7Oz5yl6LD7UR8SJnj321GIh_v1qvDfn3x2Uwp7_kuhXlE7iOXnLjJ_sDlNHKa887vTOAmmrAnT6_Zy8EEwjfHesl-ffn88_prcfvj5tv1p9vCKQFT4RB6gc6KoZe1rboSrFMt2M7axtZd39e1AxzUAK5VaCq7GALlcMCyhvVcsg-Huduc_sxIkx49OQzBREwz6QYAqqZRzUK-O5KzHbHX2-xHk_f69B0L8P4IGHImDNlE5-mZK8uqqqAuF645cC4nooyDdn4yk09xysYHLYVeA9KngPQpoEUp_1E-L_EfzXGre393_-gzahpNCIsJqTE_QKWVbheXT1UinvA |
CitedBy_id | crossref_primary_10_1183_13993003_01005_2018 crossref_primary_10_1183_09031936_00064710 crossref_primary_10_1183_09031936_00146012 crossref_primary_10_1183_13993003_00577_2017 crossref_primary_10_1183_13993003_01812_2017 crossref_primary_10_33790_jcnrc1100201 crossref_primary_10_1183_13993003_02025_2022 crossref_primary_10_1183_09031936_00008812 crossref_primary_10_1183_13993003_01622_2023 crossref_primary_10_1183_13993003_02225_2023 crossref_primary_10_1016_j_jamda_2016_08_012 crossref_primary_10_1183_09031936_00153113 crossref_primary_10_1016_j_mcna_2013_06_001 crossref_primary_10_1038_s41598_022_17261_5 crossref_primary_10_1016_j_rmed_2021_106441 crossref_primary_10_1080_17476348_2025_2458607 crossref_primary_10_4187_respcare_10757 crossref_primary_10_1164_rccm_202302_0310ST crossref_primary_10_1093_gerona_glv201 crossref_primary_10_3310_pgfar09130 crossref_primary_10_1183_09031936_00187314 crossref_primary_10_1016_j_heliyon_2024_e31176 crossref_primary_10_1111_resp_13648 crossref_primary_10_1183_13993003_00033_2020 crossref_primary_10_1016_j_anai_2013_08_013 crossref_primary_10_1183_09031936_00086313 crossref_primary_10_1183_09031936_00086510 crossref_primary_10_1183_20734735_012113 crossref_primary_10_1016_j_jcf_2024_09_009 crossref_primary_10_1183_13993003_01499_2021 crossref_primary_10_1183_13993003_02046_2020 crossref_primary_10_1159_000447246 crossref_primary_10_1136_bmjresp_2020_000575 crossref_primary_10_1007_s40520_017_0792_x crossref_primary_10_1016_j_arbres_2018_01_022 crossref_primary_10_1183_09031936_00104911 crossref_primary_10_1111_j_1532_5415_2011_03596_x crossref_primary_10_1136_thoraxjnl_2017_210477 crossref_primary_10_7759_cureus_54176 crossref_primary_10_1111_j_1440_1843_2010_01850_x crossref_primary_10_1007_s10654_012_9750_2 crossref_primary_10_1016_j_arbres_2025_02_011 crossref_primary_10_4187_respcare_07012 crossref_primary_10_1164_rccm_202011_4174LE crossref_primary_10_1513_AnnalsATS_202405_515LE crossref_primary_10_3389_fcvm_2023_1228807 crossref_primary_10_2147_COPD_S373834 crossref_primary_10_1183_13993003_01608_2022 crossref_primary_10_1097_ACO_0b013e32834e7ad2 crossref_primary_10_1016_j_resinv_2016_03_006 crossref_primary_10_2147_COPD_S492178 crossref_primary_10_1016_j_rmed_2015_11_005 crossref_primary_10_1016_j_rmed_2015_11_004 crossref_primary_10_1183_13993003_01711_2015 crossref_primary_10_1097_MCP_0000000000000943 crossref_primary_10_4082_kjfm_2018_39_2_85 crossref_primary_10_1177_1557988320922630 crossref_primary_10_1016_j_arbr_2018_01_028 crossref_primary_10_4187_respcare_01286 crossref_primary_10_1183_13993003_01326_2021 crossref_primary_10_1513_AnnalsATS_201802_104OC crossref_primary_10_4187_respcare_05515 crossref_primary_10_3109_15412555_2011_558544 crossref_primary_10_1183_13993003_00354_2024 crossref_primary_10_1186_s12877_015_0013_4 crossref_primary_10_1055_s_0043_1766119 crossref_primary_10_1177_14799731241307252 |
Cites_doi | 10.1152/ajplegacy.1948.154.3.405 10.1136/thx.34.4.569 10.1183/09031936.05.00034805 10.1016/S0195-668X(01)80001-4 10.1152/jappl.1996.81.4.1651 10.1164/ajrccm.159.4.9807121 10.1056/NEJM199810223391703 10.1164/ajrccm/140.2.379 10.1378/chest.108.3.656 10.1136/thx.47.1.14 10.1152/jappl.1999.87.3.920 10.1183/09041950.005s1693 10.1183/09031936.05.00035205 10.1136/thx.43.4.265 10.1136/thx.34.1.1 10.1016/j.rmed.2006.06.009 10.1111/j.1532-5415.2008.01969.x 10.1016/j.rmed.2008.09.016 10.1016/0895-4356(90)90070-6 |
ContentType | Journal Article |
Copyright | 2015 INIST-CNRS |
Copyright_xml | – notice: 2015 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1183/09031936.00025809 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1399-3003 |
EndPage | 882 |
ExternalDocumentID | 19741033 22555362 10_1183_09031936_00025809 erj35_4_873 |
Genre | Journal Article |
GroupedDBID | - 02 1OC 2WC 53G 55 5GY 5RE 5VS AALRV AAPBV ABFLS ABOCM ABSGY ABYBQ ACPRK ADACO ADBBV ADDZX AENEX AFFNX AJYGW ALMA_UNASSIGNED_HOLDINGS BAWUL CAG CS3 DIK E3Z EBS EJD F5P FH7 GX1 H13 INIJC KQ8 L7B O0- OK1 P2P PQEST PQQKQ R0Z RHF RHI TER WOQ X7M ZA5 ZE2 ZGI --- .55 .GJ 18M 31~ 3O- 8-1 AADJU AAFWJ AAYXX AAZMJ ABCQX ABJNI ABSQV ACEMG ACGFO ACXQS ADMOG ADYFA AFHIN AFZJQ AIZTS AJAOE BTFSW CITATION COF F9R J5H LH4 LW6 TR2 W8F ZXP ~02 IQODW CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c403t-ce3d0ecb0fd16b5923bc483b9bb7b69dd66c3ef4f3c84ea5b19334cefe263e263 |
ISSN | 0903-1936 1399-3003 |
IngestDate | Fri Jul 11 12:25:18 EDT 2025 Thu Apr 03 07:07:12 EDT 2025 Wed Apr 02 07:20:09 EDT 2025 Thu Apr 24 23:08:02 EDT 2025 Tue Jul 01 05:42:38 EDT 2025 Tue Nov 10 19:19:16 EST 2020 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Spirometry Lung function Prognosis Volume respiratory function tests Exploration Cox's proportional hazards Survival Hazard Pneumology |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c403t-ce3d0ecb0fd16b5923bc483b9bb7b69dd66c3ef4f3c84ea5b19334cefe263e263 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://erj.ersjournals.com/content/erj/35/4/873.full.pdf |
PMID | 19741033 |
PQID | 733357747 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_733357747 pubmed_primary_19741033 pascalfrancis_primary_22555362 crossref_citationtrail_10_1183_09031936_00025809 crossref_primary_10_1183_09031936_00025809 highwire_smallpub1_erj35_4_873 |
ProviderPackageCode | RHF RHI CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2010-04-01 |
PublicationDateYYYYMMDD | 2010-04-01 |
PublicationDate_xml | – month: 04 year: 2010 text: 2010-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Leeds |
PublicationPlace_xml | – name: Leeds – name: England |
PublicationTitle | The European respiratory journal |
PublicationTitleAlternate | Eur Respir J |
PublicationYear | 2010 |
Publisher | Eur Respiratory Soc Maney |
Publisher_xml | – name: Eur Respiratory Soc – name: Maney |
References | 2024102020025204000_35.4.873.5 2024102020025204000_35.4.873.6 2024102020025204000_35.4.873.3 2024102020025204000_35.4.873.4 2024102020025204000_35.4.873.7 2024102020025204000_35.4.873.8 (2024102020025204000_35.4.873.25) 1948; 154 2024102020025204000_35.4.873.21 (2024102020025204000_35.4.873.9) 1989; 140 2024102020025204000_35.4.873.22 (2024102020025204000_35.4.873.16) 1999; 159 2024102020025204000_35.4.873.23 (2024102020025204000_35.4.873.19) 1993; 12 2024102020025204000_35.4.873.27 (2024102020025204000_35.4.873.24) 1996; 81 2024102020025204000_35.4.873.10 (2024102020025204000_35.4.873.26) 1999; 87 2024102020025204000_35.4.873.11 (2024102020025204000_35.4.873.20) 1985; 132 2024102020025204000_35.4.873.14 2024102020025204000_35.4.873.15 2024102020025204000_35.4.873.12 (2024102020025204000_35.4.873.17) 2007; 2 2024102020025204000_35.4.873.13 2024102020025204000_35.4.873.18 2024102020025204000_35.4.873.2 (2024102020025204000_35.4.873.1) 1846; 29 20930208 - Eur Respir J. 2010 Sep;36(3):693; author reply 694 |
References_xml | – volume: 154 start-page: 405 year: 1948 ident: 2024102020025204000_35.4.873.25 publication-title: Am J Physiol doi: 10.1152/ajplegacy.1948.154.3.405 – ident: 2024102020025204000_35.4.873.5 doi: 10.1136/thx.34.4.569 – ident: 2024102020025204000_35.4.873.14 doi: 10.1183/09031936.05.00034805 – ident: 2024102020025204000_35.4.873.15 doi: 10.1016/S0195-668X(01)80001-4 – volume: 81 start-page: 1651 year: 1996 ident: 2024102020025204000_35.4.873.24 publication-title: J Appl Physiol doi: 10.1152/jappl.1996.81.4.1651 – volume: 159 start-page: 1267 year: 1999 ident: 2024102020025204000_35.4.873.16 publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.159.4.9807121 – volume: 2 start-page: 657 year: 2007 ident: 2024102020025204000_35.4.873.17 publication-title: Int J COPD – ident: 2024102020025204000_35.4.873.3 – ident: 2024102020025204000_35.4.873.21 doi: 10.1056/NEJM199810223391703 – volume: 140 start-page: 379 year: 1989 ident: 2024102020025204000_35.4.873.9 publication-title: Am Rev Respir Dis doi: 10.1164/ajrccm/140.2.379 – ident: 2024102020025204000_35.4.873.22 doi: 10.1378/chest.108.3.656 – ident: 2024102020025204000_35.4.873.23 doi: 10.1136/thx.47.1.14 – ident: 2024102020025204000_35.4.873.10 – volume: 87 start-page: 920 year: 1999 ident: 2024102020025204000_35.4.873.26 publication-title: J Appl Physiol doi: 10.1152/jappl.1999.87.3.920 – volume: 29 start-page: 137 year: 1846 ident: 2024102020025204000_35.4.873.1 publication-title: Med Chir Trans – ident: 2024102020025204000_35.4.873.7 doi: 10.1183/09041950.005s1693 – ident: 2024102020025204000_35.4.873.8 doi: 10.1183/09031936.05.00035205 – ident: 2024102020025204000_35.4.873.6 doi: 10.1136/thx.43.4.265 – volume: 132 start-page: 1034 year: 1985 ident: 2024102020025204000_35.4.873.20 publication-title: Am Rev Respir Dis – ident: 2024102020025204000_35.4.873.4 doi: 10.1136/thx.34.1.1 – ident: 2024102020025204000_35.4.873.13 doi: 10.1016/j.rmed.2006.06.009 – ident: 2024102020025204000_35.4.873.27 – ident: 2024102020025204000_35.4.873.2 – ident: 2024102020025204000_35.4.873.18 doi: 10.1111/j.1532-5415.2008.01969.x – ident: 2024102020025204000_35.4.873.11 doi: 10.1016/j.rmed.2008.09.016 – ident: 2024102020025204000_35.4.873.12 doi: 10.1016/0895-4356(90)90070-6 – volume: 12 start-page: 669 year: 1993 ident: 2024102020025204000_35.4.873.19 publication-title: J Heart Lung Transplant – reference: 20930208 - Eur Respir J. 2010 Sep;36(3):693; author reply 694 |
SSID | ssj0016431 |
Score | 2.2684028 |
Snippet | Spirometric lung function is partly determined by sex, age and height (Ht). Commonly, lung function is expressed as a percentage of the predicted value (PP) in... |
SourceID | proquest pubmed pascalfrancis crossref highwire |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 873 |
SubjectTerms | Adult Age Distribution Aged Biological and medical sciences Body Height Female Forced Expiratory Volume Humans Lung Diseases - diagnosis Lung Diseases - mortality Male Medical sciences Middle Aged Multivariate Analysis Pneumology Predictive Value of Tests Proportional Hazards Models Reference Values Sex Distribution Spirometry - standards Spirometry - statistics & numerical data Young Adult |
Title | New concepts for expressing forced expiratory volume in 1 s arising from survival analysis |
URI | http://erj.ersjournals.com/cgi/content/abstract/35/4/873 https://www.ncbi.nlm.nih.gov/pubmed/19741033 https://www.proquest.com/docview/733357747 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFB60gvhS6n1bLfPgk0viJGdyexSxFGUVpYXiy5C5gbKmstktxV_vmUwmyVor1ocNy5AdZvN9OXPOnBshLxKJRrJKdIRXHXFb66hWKY9yZWqWl1aWnaG4-JAfn_J3Z9nZGKvaZZesZax-_jGv5H9QxTHE1WXJ3gDZYVIcwO-IL14RYbz-E8YuOFH5vMPW1-6-9HGtPjrSufZxJHjSvSByBxzJvJ275oPdfS6_pN2gxLjoygb4GiVTndUxaTi0X01c89M1bqUVLuL553gUui5W2ku3j_H8KJ4eNDgf-RCf0p8YujC2CvrK1V5eon6DMDOYClRff6QnDp9Ix9J3LQkbre86dFWGl9C5lFx-FThXEaplJavGDSs46X_bx4bows6uKUGEKUSY4ja5k6I14RpdvP80OptQKesaK4b_1zu_cYpXV1axrb6EktIuorZu8aWyvhvK9eZKp7ac7JHd3t6grz157pNbpnlA7i76iIqH5AtyiAYOUSQNHTlEPYfoyCHqnz392tCEtrTnEHUcooFDNHDoETk9envy5jjq-21EijNYR8qAZkZJZnWSywxVf6l4CbKSspB5pXWeKzCWW1AlN3Um8ckAV8aaNAf3eUx2mvPGPCW01tyyUtqUVZbnUNTaoqpUpAnOXmSVnhEWHqNQfTF61xNlKa4Fb0ZeDj_54Sux_O3mw4CNaL_XyyVikAiz-gaZ4AJ5iDdsITZMiftblqFWNyM0QChQ4jo3Wt2Y800rCgDI0GoqZuSJh3ZcD1rnCQPYv8laD8i98XV7RnbWq415jpruWh52PP0FV7Ci-Q |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=New+concepts+for+expressing+forced+expiratory+volume+in+1+s+arising+from+survival+analysis&rft.jtitle=The+European+respiratory+journal&rft.au=Miller%2C+M.+R.&rft.au=Pedersen%2C+O.+F.&rft.date=2010-04-01&rft.issn=0903-1936&rft.eissn=1399-3003&rft.volume=35&rft.issue=4&rft.spage=873&rft.epage=882&rft_id=info:doi/10.1183%2F09031936.00025809&rft.externalDBID=n%2Fa&rft.externalDocID=10_1183_09031936_00025809 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0903-1936&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0903-1936&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0903-1936&client=summon |